The FDA announced it planned to restrict use of GLP-1 active pharmaceutical ingredients in non-FDA-approved drugs, including those from Hims & Hers and other compounding pharmacies.“These actions are ...
At a starting cost of just $49 per month, the new pills are the cheapest GLP-1 option yet. But experts say compounded drugs ...
The FDA said “decisive steps” will be taken to restrict drugs using GLP-1 active pharmaceutical ingredients in non-approved ...
Feb 6 (Reuters) - The U.S. Food and Drug Administration said on Friday it plans to restrict GLP-1 ingredients used in ...
Most women said they preferred clinic-based cervical cancer testing over at-home self-sampling, with demographics and life experiences shaping those preferences, a cross-sectional ...
FDA proposes MRD-negative and complete response endpoints to fast-track multiple myeloma drug approvals, pushing deeper molecular results over ORR.
The U.S. Food and Drug Administration said on Friday it would take action against telehealth provider Hims & Hers for its $49 ...
At-home health tests are booming—but are they reliable? Doctors explain which home tests are worth trying, which to skip, and ...
Novo Nordisk vowed to take legal action against telehealth company Hims & Hers for selling a knockoff of its weight loss pill ...
The U.S. Food and Drug Administration (FDA) will now allow food labels to claim products have "no artificial colors" as long ...
The Food and Drug Administration authorized emergency over-the-counter use of Ivomec injection to help prevent New World ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results